The effects of methamphetamine on core body temperature in the rat - PART 1: Chronic treatment and ambient temperature

Psychopharmacology

Volumn 198, Issue 3, 2008, Pages 301-311

  Myles, Benita J ^a   Jarrett, Lee Ann ^a   Broom, Susan L ^a   Speaker, H Anton ^a   Sabol, Karen E ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Drug abuse; Methamphetamine; Rat; Temperature; Tolerance

Indexed keywords

DOPAMINE; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DRUG EFFECT; DRUG TOLERANCE; ENVIRONMENTAL TEMPERATURE; HYPERTHERMIA; HYPOTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; TEMPERATURE MEASUREMENT; TREATMENT DURATION;

ANIMALS; BODY TEMPERATURE; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; DOPAMINE; ELECTROCHEMISTRY; HANDLING (PSYCHOLOGY); MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRESS, PSYCHOLOGICAL; TELEMETRY; TEMPERATURE;

EID: 44249119347     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-1061-z     Document Type: Article

References (54)

1. Ando K, Johanson CE, Seiden LS, Schuster CR (1985) Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration. Pharmacol Biochem Behav 22:737-743
2. Axt KJ, Molliver ME (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9:302-313
3. Bowyer JF, Tank AW, Newport GD, Slikker W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824
4. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580
5. Brecht ML, von Mayrhauser C, Anglin MD (2000) Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs 32:211-220
6. Cass WA, Manning MW, Dugan MT (1998) Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats. Neurosci Lett 248:175-178
7. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65-79
8. Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16-32
9. Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW (2001) Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) 155:397-404
10. Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, Perez-Reyes M (1992) Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 20:856-862
11. Crawshaw LI (1972) Effects of intracerebral 5-hydroxytryptamine injection on thermoregulation in rat. Physiol Behav 9:133-140
12. Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2007) Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559:46-54
13. Faunt JE, Crocker AD (1987) The effects of selective dopamine receptor agonists and antagonists on body temperature in rats. Eur J Pharmacol 133:243-247
14. Finnegan KT, Ricaurte G, Seiden LS, Schuster CR (1982) Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacology 77:43-52
15. Fukumura M, Cappon GD, Pu C, Broening HW, Vorhees CV (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res 806:1-7
16. Gordon CJ (1990) Thermal biology of the laboratory rat. Physiol Behav 47:963-991
17. Gordon CJ (1993) Temperature regulation in laboratory rodents. Cambridge University Press, New York
18. Gudelsky GA, Koenig JI, Meltzer HY (1985) Altered responses to serotonergic agents in Fawn-Hooded rats. Pharmacol Biochem Behav 22:489-492
19. Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307-1313
20. Gygi MP, Gygi SP, Johnson M, Wilkins DG, Gibb JW, Hanson GR (1996) Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35:751-757
21. Hansen MG, Whishaw IQ (1973) The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat. Psychopharmacologia 29:33-44
22. Ishigami A, Kubo S, Gotohda T, Tokunaga I (2003) The application of immunohistochemical findings in the diagnosis in methamphetamine-related death-two forensic autopsy cases. J Med Invest 50:112-116
23. Johnson-Davis KL, Truong JG, Fleckenstein AE, Wilkins DG (2004) Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 309:578-586
24. Keppel G (1991) Design and analysis: a researcher's handbook. Prentice Hall, Englewood Cliffs, NJ
25. Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi K, Hasegawa T (2003) Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats. Eur J Pharmacol 464:39-48
26. Lee TF, Mora F, Myers RD (1985) Dopamine and thermoregulation: an evaluation with special reference to dopaminergic pathways. Neurosci Biobehav Rev 9:589-598
27. Lewander T (1971) A mechanism for the development of tolerance to amphetamine in rats. Psychopharmacologia 21:17-31
28. Makisumi T, Yoshida K, Watanabe T, Tan N, Murakami N, Morimoto A (1998) Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol 363:107-112
29. Malberg J, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086-5094
30. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
31. Myles BM, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat. Part 2: an escalating regimen. Psychopharmacology DOI 10.1007/s00213-007-1060-0
32. NRC (1996) Guide for the care and use of laboratory animals. National Academy, Washington, DC
33. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA (2002) Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26:53-63
34. Perez-Reyes M, White WR, McDonald SA, Hicks RE, Jeffcoat AR, Hill JM, Cook CE (1991) Clinical effects of daily methamphetamine administration. Clin Neuropharmacol 14:352-358
35. Reiber C, Galloway G, Cohen J, Hsu JC, Lord RH (2000) A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months. J Psychoactive Drugs 32:183-191
36. Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153-160
37. Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE (2002) Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur J Pharmacol 435:181-185
38. Rusyniak DE, Zaretskaia MV, Zaretsky DV, DiMicco JA (2007) 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin- induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. J Pharmacol Exp Ther 323:477-487
39. Sabol KE, Richards JB, Yung K (2000) The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry. J Pharmacol Exp Ther 294:850-863
40. Sabol KE, Roach JT, Broom SL, Ferreira C, Preau MM (2001) Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res 892:122-129
41. Salmi P, Ahlenius S (1998) Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. Pharmacol Toxicol 82:122-127
42. Salmi P, Jimenez P, Ahlenius S (1993) Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 236:395-400
43. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV (2002) Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 111:65-74
44. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7
45. Schmidt CJ, Black CK, Taylor VL (1991) l-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4- methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. Eur J Pharmacol 203:41-49
46. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W (2002a) Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74
47. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W (2002b) A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21:35-44
48. Sprague JE, Banks ML, Cook VJ, Mills EM (2003) Hypothalamic-pituitary- thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). J Pharmacol Exp Ther 305:159-166
49. Sprague JE, Yang X, Sommers J, Gilman TL, Mills EM (2007) Roles of norepinephrine, free fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. J Pharmacol Exp Ther 320:274-280
50. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028-6036
51. Thornhill JA, Hirst M, Gowdey CW (1977) Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats. Can J Physiol Pharmacol 55:1170-1178
52. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382
53. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160
54. Yehuda S, Wurtman RJ (1972) The effects of d-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci I 11:851-859